GC Biopharma partners with Eubiologics to produce cholera vaccines
Eubiologics, a company specialising in the development and production of Euvichol, will oversee the bulk vaccine production, while…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Aug 23
Eubiologics, a company specialising in the development and production of Euvichol, will oversee the bulk vaccine production, while…
24 Aug 23
FDA accepted Pfizer and Astellas’ supplemental New Drug Application (sNDA) for Xtandi, expanding its indication to include patients…
24 Aug 23
The funding, which follows the firm’s launch with a $100m Series A financing in March this year, will…
24 Aug 23
Under the terms of the agreement, Aardvark Therapeutics will have the global development and commercialisation rights to ADAIR…
24 Aug 23
The expansion significantly boosts cell therapy capabilities and serves as a complementary addition to suspension and adhesion viral…
24 Aug 23
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators. We are continuing the study until…
23 Aug 23
The funding under Project NextGen includes $1bn to BARDA partners for vaccine clinical trials, $326m to Regeneron for…
23 Aug 23
The trial compared Retevmo against physician's choice of the MKIs vandetanib or cabozantinib as an initial treatment and…
23 Aug 23
Under the terms of the cooperation agreement, Sanyou will leverage its globally renowned core technology platform to undertake…
23 Aug 23
Groundbreaking discovery to be used as basis for Verismo's SynKir-310 to target blood cancer